Early and sustained reduction in headache impact in people with CM after eptinezumab treatment: HIT-6 item analysis in the phase 3 promise-2 trial

Authors
Category Primary study
ConferenceHeadache
Year 2019
This article has no abstract
Epistemonikos ID: 46c80ac98f15762ff9be37c427fa2c0af85651bc
First added on: Apr 30, 2026